Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pritchard

Showing results (521-530 of 533) with videos related to

Pageof 54
Sort By:
Cancer Research|November 1, 1981
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studiesD T Purtilo, K Sakamoto, A K Saemundsen, et al.
Medical and Pediatric Oncology|September 1, 1997
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte SocietyB E Favara, A C Feller, M Pauli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2022
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal CancerJames M Price, Hitesh B Mistry, Guy Betts, et al.
Global Change Biology|March 21, 2024
Climate change disrupts the seasonal coupling of plant and soil microbial nutrient cycling in an alpine ecosystemArthur A D Broadbent, Lindsay K Newbold, William J Pritchard, et al.
The New England Journal of Medicine|February 21, 2003
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of boneHolcombe E Grier, Mark D Krailo, Nancy J Tarbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group studyJames S Miser, Mark D Krailo, Nancy J Tarbell, et al.
Cancer Research Communications|December 5, 2022
Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacyCarmen A Widmer, Ismar Klebic, Natalya Domanitskaya, et al.
Blood|January 12, 2022
Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALLMateusz Antoszewski, Nadine Fournier, Gustavo A Ruiz Buendía, et al.
Pediatric Blood & Cancer|June 23, 2007
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology GroupJames S Miser, Robert E Goldsby, Zhengjia Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
Mammalian life depends on two distinct pathways of DNA damage toleranceOlimpia Alessandra Buoninfante, Bas Pilzecker, Aldo Spanjaard, et al.
Pageof 54

Showing results (521-530 of 533) with videos related to

Sort By:
Pageof 54
Cancer Research|November 1, 1981
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studiesD T Purtilo, K Sakamoto, A K Saemundsen, et al.
Medical and Pediatric Oncology|September 1, 1997
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte SocietyB E Favara, A C Feller, M Pauli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2022
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal CancerJames M Price, Hitesh B Mistry, Guy Betts, et al.
Global Change Biology|March 21, 2024
Climate change disrupts the seasonal coupling of plant and soil microbial nutrient cycling in an alpine ecosystemArthur A D Broadbent, Lindsay K Newbold, William J Pritchard, et al.
The New England Journal of Medicine|February 21, 2003
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of boneHolcombe E Grier, Mark D Krailo, Nancy J Tarbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group studyJames S Miser, Mark D Krailo, Nancy J Tarbell, et al.
Cancer Research Communications|December 5, 2022
Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacyCarmen A Widmer, Ismar Klebic, Natalya Domanitskaya, et al.
Blood|January 12, 2022
Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALLMateusz Antoszewski, Nadine Fournier, Gustavo A Ruiz Buendía, et al.
Pediatric Blood & Cancer|June 23, 2007
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology GroupJames S Miser, Robert E Goldsby, Zhengjia Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
Mammalian life depends on two distinct pathways of DNA damage toleranceOlimpia Alessandra Buoninfante, Bas Pilzecker, Aldo Spanjaard, et al.
Pageof 54